On October 8, 2024, PhRMA held a media briefing to address growing concerns over the Inflation Reduction Act (IRA) and its effects on the biopharmaceutical industry, Medicare Part D beneficiaries, and ...
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent an Untitled Letter to Kaleo, Inc., regarding a social media post made by an influencer for its ...